US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 516.740
  • +14.290+2.84%
Close Nov 8 16:00 ET
  • 516.910
  • +0.170+0.03%
Post 20:01 ET
133.08BMarket Cap-271968P/E (TTM)

Vertex Pharmaceuticals Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Nov 9, 2024

Based on 28 analysts giving stock ratings to Vertex Pharmaceuticals in the past 3 months

Buy

  • Buy

    60.71%
  • Hold

    32.14%
  • Sell

    7.14%

Price Target

Updated: Nov 9, 2024

The average Vertex Pharmaceuticals stock price target is 517.18 with a max estimate of 600.00 and a min estimate of 325.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Nov 9, 2024

Buy

  • Buy

    60.71%
  • Hold

    32.14%
  • Sell

    7.14%

Price Target

Updated: Nov 9, 2024

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data